{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T06:07:21Z","timestamp":1750399641453},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s11910-014-0456-6","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T05:57:33Z","timestamp":1401256653000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neurology of Rheumatologic Disorders"],"prefix":"10.1007","volume":"14","author":[{"given":"Amre","family":"Nouh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olimpia","family":"Carbunar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Ruland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"issue":"9894","key":"456_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius M, D\u00f6rner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet. 2013;382(9894):819\u201331.","journal-title":"Lancet"},{"issue":"9894","key":"456_CR2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","volume":"382","author":"F Goldblatt","year":"2013","unstructured":"Goldblatt F, O'Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet. 2013;382(9894):797\u2013808. This article reviews new classification, nomenclature, and diagnostic criteria incorporating newer autoantibodies to facilitate an earlier and more specific diagnosis and treatment initiation for several common rheumatologic disorders.","journal-title":"Lancet"},{"issue":"5","key":"456_CR3","first-page":"S120","volume":"23","author":"GKW Lam","year":"2005","unstructured":"Lam GKW, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol. 2005;23(5):S120.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"456_CR4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","volume":"69","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Lammie GA, Scolding NJ. CNS lupus A study of 41 patients. Neurology. 2007;69(7):644\u201354.","journal-title":"Neurology"},{"issue":"4","key":"456_CR5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"MH Liang","year":"1999","unstructured":"Liang MH, Corzillius M, Bae SC, Lew RA, Fortin PR, Gordon C, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599\u2013608.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"456_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","volume":"6","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol. 2010;6(6):358\u201367.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"456_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","volume":"41","author":"FGI Jennekens","year":"2002","unstructured":"Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology. 2002;41(6):619\u201330.","journal-title":"Rheumatology"},{"issue":"5","key":"456_CR8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.STR.20.5.583","volume":"20","author":"N Futrell","year":"1989","unstructured":"Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20(5):583\u201391.","journal-title":"Stroke"},{"issue":"9","key":"456_CR9","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","volume":"52","author":"CC Mok","year":"2005","unstructured":"Mok CC, Tang SSK, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum. 2005;52(9):2774\u201382.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"456_CR10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","volume":"18","author":"R Cervera","year":"2009","unstructured":"Cervera R, Boffa MC, Khamashta MA, Hughes GRV. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009;18(10):889\u201393.","journal-title":"Lupus"},{"issue":"11","key":"456_CR11","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1002\/art.38106","volume":"65","author":"JG Hanly","year":"2013","unstructured":"Hanly JG, Urowitz MB, O'Keeffe AG, Gordon C, Bae SC, Sanchez\u2010Guerrero J, et al. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum. 2013;65(11):2887\u201397.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"456_CR12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/37.3.300","volume":"37","author":"PP Sfikakis","year":"1998","unstructured":"Sfikakis PP, Mitsikostas DD, Manoussakis MN, Foukaneli D, Moutsopoulos HM. Headache in systemic lupus erythematosus: a controlled study. Rheumatology. 1998;37(3):300\u20133.","journal-title":"Rheumatology"},{"issue":"10","key":"456_CR13","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","volume":"63","author":"S Appenzeller","year":"2004","unstructured":"Appenzeller S, Cendes F, Costallat LT. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004;63(10):1808\u201312.","journal-title":"Neurology"},{"issue":"3","key":"456_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/NRL.0b013e31818ff9aa","volume":"15","author":"BM Greenberg","year":"2009","unstructured":"Greenberg BM. The neurologic manifestations of systemic lupus erythematosus. Neurologist. 2009;15(3):115\u201321.","journal-title":"Neurologist"},{"issue":"3","key":"456_CR15","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/epi.12012","volume":"54","author":"T Toyota","year":"2013","unstructured":"Toyota T, Akamatsu N, Tanaka A, Shouzaki T, Tsuji S, Saito K, et al. Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosus. Epilepsia. 2013;54(3):e33\u20136.","journal-title":"Epilepsia"},{"issue":"6","key":"456_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/rheumatology\/41.6.605","volume":"41","author":"FGI Jennekens","year":"2002","unstructured":"Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology. 2002;41(6):605\u201318.","journal-title":"Rheumatology"},{"issue":"12","key":"456_CR17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1191\/0961203303lu497oa","volume":"12","author":"SD Denburg","year":"2003","unstructured":"Denburg SD, Denburg JA. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus. 2003;12(12):883\u201390.","journal-title":"Lupus"},{"issue":"4","key":"456_CR18","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/rheumatology\/keh532","volume":"44","author":"S Ferreira","year":"2005","unstructured":"Ferreira S, D'Cruz DP, Hughes GRV. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology. 2005;44(4):434\u201342.","journal-title":"Rheumatology"},{"issue":"2","key":"456_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.59.2.120","volume":"59","author":"B Kovacs","year":"2000","unstructured":"Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59(2):120\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"456_CR20","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","volume":"120","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm. 2013;120(11):1579\u201389.","journal-title":"J Neural Transm"},{"issue":"4","key":"456_CR21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00296-013-2900-3","volume":"34","author":"GL Erre","year":"2014","unstructured":"Erre GL, Bosincu L, Faedda R, Fenu P, Masala A, Sanna M, et al. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study. Rheumatol Int. 2014;34(4):535\u201341.","journal-title":"Rheumatol Int"},{"issue":"2","key":"456_CR22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2011.09.001","volume":"11","author":"M Prete","year":"2011","unstructured":"Prete M, Racanelli V, Digiglio L, Vacca A, Dammacco F, Perosa F. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev. 2011;11(2):123\u201331.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"456_CR23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/apmr.2002.29665","volume":"83","author":"LD Blankenship","year":"2002","unstructured":"Blankenship LD, Basford JR, Strommen JA, Andersen RJ. Hypoglossal nerve palsy from cervical spine involvement in rheumatoid arthritis: 3 case reports. Arch Phys Med Rehabil. 2002;83(2):269\u201372.","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"456_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00019052-200406000-00014","volume":"17","author":"DS Younger","year":"2004","unstructured":"Younger DS. Vasculitis of the nervous system. Curr Opin Neurol. 2004;17(3):317\u201336.","journal-title":"Curr Opin Neurol"},{"issue":"856","key":"456_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1259\/bjr.72.856.10474506","volume":"72","author":"AM A\u011fildere","year":"1999","unstructured":"A\u011fildere AM, Tutar NU, Y\u00fccel E, Co\u015fkun M, Benli S, Aydin P. Pachymeningitis and optic neuritis in rheumatoid arthritis: MRI findings. Br J Radiol. 1999;72(856):404\u20137.","journal-title":"Br J Radiol"},{"issue":"2","key":"456_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/PL00011193","volume":"20","author":"AE Y\u00fccel","year":"2001","unstructured":"Y\u00fccel AE, Kart H, Aydin P, A\u011fildere AM, Benli S, Altin\u00f6rs N, et al. Pachymeningitis and optic neuritis in rheumatoid arthritis: successful treatment with cyclophosphamide. Clin Rheumatol. 2001;20(2):136\u20139.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"456_CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0049-0172(96)80007-2","volume":"25","author":"\u00d3 Mir\u00f3","year":"1996","unstructured":"Mir\u00f3 \u00d3, Pedrol E, Casademont J, Garc\u00eda-Carrasco M, Sanmarti R, Cebri\u00e1n M, et al. Muscle involvement in rheumatoid arthritis: clinicopathological study of 21 symptomatic cases. Semin Arthritis Rheum. 1996;25(6):421\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"456_CR28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semarthrit.2010.05.005","volume":"40","author":"JM Kahlenberg","year":"2011","unstructured":"Kahlenberg JM. Neuromyelitis spectrum disorder as an initial presentation of primary Sjogren\u2019s syndrome. Semin Arthritis Rheum. 2011;40(4):343\u20138.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"456_CR29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, DeSeze J, Fauchais A, Hachulla E, Stojkovic T, et al. Neurologic manifestation in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83(5):280\u201391.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"456_CR30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.57.8.983","volume":"57","author":"F Gemignani","year":"1994","unstructured":"Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, et al. Peripheral neuropathy associated with primary Sj\u00f6gren's syndrome. J Neurol Neurosurg Psychiatry. 1994;57(8):983\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"456_CR31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.63.11.1612","volume":"63","author":"LG Goransson","year":"2006","unstructured":"Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary Sj\u00f6gren syndrome: a population-based study. Arch Neurol. 2006;63(11):1612\u20135.","journal-title":"Arch Neurol"},{"key":"456_CR32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2003.019497","volume":"63","author":"FC Soliotis","year":"2004","unstructured":"Soliotis FC, Mavragani CP, Moutsopoulos HM. Central nervous system involvement in Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2004;63:616\u201320.","journal-title":"Ann Rheum Dis"},{"key":"456_CR33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00023210-200115080-00003","volume":"15","author":"M Govoni","year":"2001","unstructured":"Govoni M, Padovan M, Rizzo N, Trotta F. CNS involvement in primary Sj\u00f6gren\u2019s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs. 2001;15:597\u2013607.","journal-title":"CNS Drugs"},{"issue":"3","key":"456_CR34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jocn.2013.04.019","volume":"21","author":"R Sharma","year":"2014","unstructured":"Sharma R, Chilukuri V, Sarma AK, Gokhale S. Primary Sjogren\u2019s syndrome presenting as acute cerebellitis. J Clin Neurosci. 2014;21(3):508\u20139.","journal-title":"J Clin Neurosci"},{"key":"456_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410250117","volume":"25","author":"JH Noseworthy","year":"1989","unstructured":"Noseworthy JH, Bass BH, Vandervoort MK, et al. The prevalence of primary Sj\u00f6gren\u2019s syndrome in a multiple sclerosis population. Ann Neurol. 1989;25:95\u20138.","journal-title":"Ann Neurol"},{"key":"456_CR36","first-page":"290","volume":"77","author":"A Theodoridou","year":"2006","unstructured":"Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry. 2006;77:290\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"456_CR37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1468-1331.2004.00822.x","volume":"11","author":"A Bourahoui","year":"2004","unstructured":"Bourahoui A, De Seze J, Guttierez R, et al. CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol. 2004;11:525\u20139.","journal-title":"Eur J Neurol"},{"key":"456_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000052095","volume":"45","author":"KY Tsai","year":"2001","unstructured":"Tsai KY, Tsai CP, Liao N. Sjogren\u2019s syndrome with central nervous system involvement presenting as multiple sclerosis with failure response to beta-interferon. Eur Neurol. 2001;45:59\u201360.","journal-title":"Eur Neurol"},{"issue":"6","key":"456_CR39","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<800::AID-MUS14>3.0.CO;2-W","volume":"21","author":"RG Auger","year":"1998","unstructured":"Auger RG. Role of the masseter reflex in the assessment of subacute sensory neuropathy. Muscle Nerve. 1998;21(6):800\u20131.","journal-title":"Muscle Nerve"},{"issue":"5","key":"456_CR40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mus.10470","volume":"28","author":"KC Gorson","year":"2003","unstructured":"Gorson KC, Ropper AH. Positive salivary gland biopsy, Sj\u00f6gren syndrome, and neuropathy: clinical implications. Muscle Nerve. 2003;28(5):553\u201360.","journal-title":"Muscle Nerve"},{"issue":"7","key":"456_CR41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00001756-200505120-00005","volume":"16","author":"Y Murata","year":"2005","unstructured":"Murata Y, Maeda K, Kawai H, et al. Antiganglion neuron antibodies correlate with neuropathy in Sj\u00f6gren's syndrome. Neuroreport. 2005;16(7):677\u201381.","journal-title":"Neuroreport"},{"issue":"3","key":"456_CR42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/(SICI)1097-4598(199903)22:3<404::AID-MUS15>3.0.CO;2-E","volume":"22","author":"JS Katz","year":"1999","unstructured":"Katz JS, Houroupian D, Ross MA. Multisystem neuronal involvement and sicca complex: broadening the spectrum of complications. Muscle Nerve. 1999;22(3):404\u20137.","journal-title":"Muscle Nerve"},{"issue":"2","key":"456_CR43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jbspin.2008.03.010","volume":"76","author":"MA Rafai","year":"2009","unstructured":"Rafai MA, Boulaajaj FZ, Moutawakil F, Addali N, El Moutawakkil B, Fadel H, et al. Neurological manifestations revealing primitive Gougerote\u2013Sjogren syndrome: 9 cases. Joint Bone Spine. 2009;76(2):139\u201345.","journal-title":"Joint Bone Spine"},{"issue":"10 Pt 1","key":"456_CR44","first-page":"959","volume":"158","author":"C Lafitte","year":"2002","unstructured":"Lafitte C, Amoura Z, Cacoub P, Pradat-Diehl P, Picq C, Salachas F, et al. Neurological complications of primary Sj\u00f6gren\u2019s syndrome. Rev Neurol (Paris). 2002;158(10 Pt 1):959\u201365.","journal-title":"Rev Neurol (Paris)"},{"key":"456_CR45","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med. 1991;325:1487\u201398.","journal-title":"N Engl J Med"},{"key":"456_CR46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology. 2002;41:22\u20136.","journal-title":"Rheumatology"},{"issue":"2","key":"456_CR47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneur.1970.00480200032003","volume":"22","author":"RM Gordon","year":"1970","unstructured":"Gordon RM, Silverstein A. Neurological manifestations in progressive systemic sclerosis. Arch Neurol. 1970;22(2):126.","journal-title":"Arch Neurol"},{"issue":"12","key":"456_CR48","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","volume":"49","author":"L Averbuch-Heller","year":"1992","unstructured":"Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 1992;49(12):1292\u20135.","journal-title":"Arch Neurol"},{"issue":"2","key":"456_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/03009749409103029","volume":"23","author":"M Hietarinta","year":"1994","unstructured":"Hietarinta M, Lassila O. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol. 1994;23(2):64.","journal-title":"Scand J Rheumatol"},{"key":"456_CR50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1422.029","volume":"1108","author":"B Ranque","year":"2007","unstructured":"Ranque B, Authier FJ. Systemic sclerosis-associated myopathy. Ann N Y Acad Sci. 2007;1108:268\u201382.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"456_CR51","first-page":"60","volume":"36","author":"TN Wise","year":"1975","unstructured":"Wise TN, Ginzler EM. Scleroderma cerebritis, an usual manifestation of progressive systemic sclerosis. Dis Nerv Syst. 1975;36(2):60\u20132.","journal-title":"Dis Nerv Syst"},{"issue":"6","key":"456_CR52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00401-010-0746-2","volume":"120","author":"KM Lindstrom","year":"2010","unstructured":"Lindstrom KM, Cousar JB, Lopes MBS. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120(6):765\u201376.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"456_CR53","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamaneurol.2013.658","volume":"70","author":"K Ohyama","year":"2013","unstructured":"Ohyama K, Koike H, Iijima M, Hashimoto R, Tomita M, Kawagashira Y, et al. IgG4-related neuropathy: a case report. JAMA Neurol. 2013;70(4):502\u20135.","journal-title":"JAMA Neurol"},{"issue":"1","key":"456_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1\u201311. This is an updated comprehensive nomenclature and classification scheme for vasculitis in patients with rheumatologic conditions, other associated systemic disorders, and infectious diseases.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"456_CR55","first-page":"75","volume":"20","author":"MG Pomper","year":"1999","unstructured":"Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. Am J Neuroradiol. 1999;20(1):75\u201385.","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"456_CR56","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1474-4422(11)70081-3","volume":"10","author":"RA Hajj-Ali","year":"2011","unstructured":"Hajj-Ali RA, Singhal AB, Benseler S, Molloy E, Calabrese LH. Primary angiitis of the CNS. Lancet Neurol. 2011;10(6):561\u201372. This is a detailed overview of the clinical presentation and diagnostic challenges distinguishing primary angiitis of the CNS from vasculitis associated with other disorders.","journal-title":"Lancet Neurol"},{"issue":"11","key":"456_CR57","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Beh\u00e7et's syndrome. Brain. 1999;122(11):2183\u201394.","journal-title":"Brain"},{"issue":"2","key":"456_CR58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","volume":"8","author":"A Al-Araji","year":"2009","unstructured":"Al-Araji A, Kidd DP. Neuro-Beh\u00e7et's disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8(2):192\u2013204.","journal-title":"Lancet Neurol"},{"issue":"883","key":"456_CR59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/pgmj.75.883.262","volume":"75","author":"JG Berrocal","year":"1999","unstructured":"Berrocal JG, Vargas JA, Vaquero M, y Cajal SR, Ram\u00edrez-Camacho RA. Cogan's syndrome: an oculo-audiovestibular disease. Postgrad Med J. 1999;75(883):262\u20134.","journal-title":"Postgrad Med J"},{"issue":"3","key":"456_CR60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.autrev.2012.07.012","volume":"12","author":"A Greco","year":"2013","unstructured":"Greco A, Gallo A, Fusconi M, Magliulo G, Turchetta R, Marinelli C, et al. Cogan's syndrome: an autoimmune inner ear disease. Autoimmun Rev. 2013;12(3):396\u2013400. This is a review of the current understanding regarding the pathophysiology of Cogan\u2019s syndrome, the causes of Cogan\u2019s syndrome, and strategies for treating Cogan\u2019s syndrome.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"456_CR61","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261\u201371.","journal-title":"N Engl J Med"},{"issue":"6","key":"456_CR62","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","volume":"118","author":"MD Walvick","year":"2011","unstructured":"Walvick MD, Walvick MP. Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology. 2011;118(6):1201\u20134.","journal-title":"Ophthalmology"},{"issue":"7","key":"456_CR63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrrheum.2010.82","volume":"6","author":"JC Mason","year":"2010","unstructured":"Mason JC. Takayasu arteritis\u2014advances in diagnosis and management. Nat Rev Rheumatol. 2010;6(7):406\u201315.","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"456_CR64","first-page":"553","volume":"153","author":"MR Rosenberg","year":"1990","unstructured":"Rosenberg MR, Parshley M, Gibson S, Wernick R. Central nervous system polyarteritis nodosa. West J Med. 1990;153(5):553\u20136.","journal-title":"West J Med"},{"issue":"1","key":"456_CR65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.65.1.10","volume":"65","author":"PM Moore","year":"1998","unstructured":"Moore PM, Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998;65(1):10\u201322.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"456_CR66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","volume":"44","author":"M Gayraud","year":"2001","unstructured":"Gayraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long\u2010term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg\u2010Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44(3):666\u201375.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"456_CR67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2011.11.022","volume":"315","author":"JI Takanashi","year":"2012","unstructured":"Takanashi JI, Shirai K, Sugawara Y, Okamoto Y, Obonai T, Terada H. Kawasaki disease complicated by mild encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci. 2012;315(1):167\u20139.","journal-title":"J Neurol Sci"},{"issue":"6","key":"456_CR68","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00006454-199806000-00008","volume":"17","author":"LD Dengler","year":"1998","unstructured":"Dengler LD, Capparelli EV, Bastian JF, Bradley DJ, Glode MP, Santa S, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J. 1998;17(6):478\u201381.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"456_CR69","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cupe.2004.09.002","volume":"15","author":"EJ Tizard","year":"2005","unstructured":"Tizard EJ. Complications of Kawasaki disease. Curr Paediatr. 2005;15(1):62\u20138.","journal-title":"Curr Paediatr"},{"key":"456_CR70","unstructured":"Watts RA, Dharmapalaiah C. ANCA-associated vasculitis. Ultrasound. 2011(2012)."},{"issue":"21","key":"456_CR71","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","volume":"337","author":"JC Jennette","year":"1997","unstructured":"Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21):1512\u201323.","journal-title":"N Engl J Med"},{"issue":"6","key":"456_CR72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneurol.2009.76","volume":"66","author":"J Birnbaum","year":"2009","unstructured":"Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Arch Neurol. 2009;66(6):704\u20139.","journal-title":"Arch Neurol"},{"issue":"4","key":"456_CR73","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/clinids\/20.4.1010","volume":"20","author":"T Somer","year":"1995","unstructured":"Somer T, Finegold SM. Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis. 1995;20(4):1010\u201336.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"456_CR74","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0049-0172(84)90010-6","volume":"14","author":"BF Dickey","year":"1984","unstructured":"Dickey BF, Myers AR. Pulmonary disease in polymyositis\/dermatomyositis. Semin Arthritis Rheum. 1984;14(1):60.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"456_CR75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","volume":"61","author":"MF Van der Meulen","year":"2003","unstructured":"Van der Meulen MF, Bronner IM, et al. Polymyositis: an overdiagnosed entity. Neurology. 2003;61(3):316\u201321.","journal-title":"Neurology"},{"issue":"4","key":"456_CR76","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-857X(21)00074-0","volume":"20","author":"JP Callen","year":"1994","unstructured":"Callen JP. Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis and inclusion body myositis. Rheum Dis Clin N Am. 1994;20(4):943\u201353.","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"456_CR77","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","volume":"15","author":"MC Hochberg","year":"1986","unstructured":"Hochberg MC, Feldman D, et al. Adult onset polymyositis\/dermatomyositis. An analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum. 1986;15(3):168\u201378.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"456_CR78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","volume":"21","author":"BM Koffman","year":"1998","unstructured":"Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve. 1998;21(1):115\u20137.","journal-title":"Muscle Nerve"},{"issue":"1","key":"456_CR79","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","volume":"98","author":"MJ Garlepp","year":"1994","unstructured":"Garlepp MJ, Laing B, Ollier W, Mastaglia FL. HLA associations with inclusion body myositis. Clin Exp Immunol. 1994;98(1):40\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"456_CR80","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","volume":"175","author":"PO Carstens","year":"2014","unstructured":"Carstens PO, Schmidt J. Diagnosis, pathogenesis and treatment of myositis: recent advances. Clin Exp Immunol. 2014;175(3):349\u201358.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"456_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-012-0321-4","volume":"13","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Inclusion body myositis. Curr Neurol Neurosci Rep. 2013;13(1):1\u20139.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"456_CR82","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","volume":"87","author":"P Delaney","year":"1977","unstructured":"Delaney P. Neurologic manifestation of sarcoidosis. Ann Intern Med. 1977;87(3):336\u201345.","journal-title":"Ann Intern Med"},{"key":"456_CR83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.semarthrit.2004.07.011","volume":"34","author":"TS Spencer","year":"2005","unstructured":"Spencer TS, Campellone JV, Maldonado I, Huang N, Usmani Q, Reginato AJ. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum. 2005;34:649\u201361.","journal-title":"Semin Arthritis Rheum"},{"key":"456_CR84","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","volume":"42","author":"BJ Stern","year":"1985","unstructured":"Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and neurological manifestations. Arch Neurol. 1985;42:909\u201317.","journal-title":"Arch Neurol"},{"key":"456_CR85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000076534","volume":"51","author":"C Kellinghaus","year":"2004","unstructured":"Kellinghaus C, Schilling M, Ludemann P. Neurosarcoidosis: clinical experience and diagnostic pitfalls. Eur Neurol. 2004;51:84\u20138.","journal-title":"Eur Neurol"},{"key":"456_CR86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0090-3019(81)80039-0","volume":"15","author":"MA Whelan","year":"1981","unstructured":"Whelan MA, Stern J. Sarcoidosis presenting as a posterior fossa mass. Surg Neurol. 1981;15:455\u20137.","journal-title":"Surg Neurol"},{"key":"456_CR87","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1212\/WNL.35.8.1220","volume":"35","author":"V Oksanen","year":"1985","unstructured":"Oksanen V, Fyhrquist F, Somer H, Gronhagen-Riska C. Angiotensin converting enzyme in cerebrospinal fluid: a new assay. Neurology. 1985;35:1220\u20133.","journal-title":"Neurology"},{"issue":"1","key":"456_CR88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1378\/chest.124.1.186","volume":"124","author":"JC Grutters","year":"2003","unstructured":"Grutters JC, Fellrath JM, Mulder L, Janssen R, van den Bosch JM, van Velzen-Blad H. Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation. Chest. 2003;124(1):186\u201395.","journal-title":"Chest"},{"issue":"3","key":"456_CR89","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/WCO.0b013e3283608459","volume":"26","author":"BM Segal","year":"2013","unstructured":"Segal BM. Neurosarcoidosis: diagnostic approaches and therapeutic strategies. Curr Opin Neurol. 2013;26(3):307\u201313. This article reviews the epidemiology of, clinical presentation of, pathophysiology of, diagnostic approach for, and treatment strategies for sarcoidosis of the CNS.","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"456_CR90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005792-199009000-00001","volume":"69","author":"C Chapelon","year":"1990","unstructured":"Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore). 1990;69(5):261\u201376.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"456_CR91","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","volume":"22","author":"A El Maghraoui","year":"2011","unstructured":"El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011;22(6):554\u201360.","journal-title":"Eur J Intern Med"},{"issue":"1002","key":"456_CR92","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1259\/bjr\/45816561","volume":"84","author":"CC Liu","year":"2011","unstructured":"Liu CC, Lin YC, Lo CP, Chang TP. Cauda equina syndrome and dural ectasia: rare manifestations in chronic ankylosing spondylitis. Br J Radiol. 2011;84(1002):e123\u20135.","journal-title":"Br J Radiol"},{"issue":"Suppl 2","key":"456_CR93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbmr.5650140218","volume":"14","author":"A Poncelet","year":"1999","unstructured":"Poncelet A. The neurologic complications of Paget's disease. J Bone Miner Res. 1999;14 Suppl 2:88\u201391.","journal-title":"J Bone Miner Res"},{"issue":"8","key":"456_CR94","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","volume":"10","author":"KR Carson","year":"2009","unstructured":"Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, et al. Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) project. Lancet Oncol. 2009;10(8):816\u201324.","journal-title":"Lancet Oncol"},{"issue":"9","key":"456_CR95","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","volume":"64","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. 2012;64(9):3043\u201351. This article reviews cases of PML associated with rheumatologic disorders reported to the FDA Adverse Event Reporting System database and discusses the role of biological agents as a cause.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"456_CR96","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol. 2011;68(9):1156\u201364.","journal-title":"Arch Neurol"},{"issue":"12","key":"456_CR97","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","volume":"60","author":"ES Molloy","year":"2009","unstructured":"Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 2009;60(12):3761\u20135.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"456_CR98","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/art.22657","volume":"56","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum. 2007;56(7):2116\u201328.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"456_CR99","first-page":"985","volume":"120","author":"R Foroozan","year":"2002","unstructured":"Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol. 2002;120(7):985\u20137.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"456_CR100","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR, Oliverio PJ, Sandberg G, Crayton H, et al. Demyelination occurring during anti\u2013tumor necrosis factor \u03b1 therapy for inflammatory arthritides. Arthritis Rheum. 2001;44(12):2862\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"456_CR101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcl005","volume":"99","author":"N Sofat","year":"2006","unstructured":"Sofat N, Malik O, Higgens CS. Neurological involvement in patients with rheumatic disease. QJM. 2006;99(2):69\u201379.","journal-title":"QJM"},{"issue":"11","key":"456_CR102","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","volume":"60","author":"JB Caress","year":"2003","unstructured":"Caress JB, Cartwright MS, Donofrio PD, Peacock JE. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology. 2003;60(11):1822\u20134.","journal-title":"Neurology"},{"issue":"3","key":"456_CR103","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/BOR.0b013e32834456bf","volume":"23","author":"SJ Katz","year":"2011","unstructured":"Katz SJ, Russell AS. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action. Curr Opin Rheumatol. 2011;23(3):278\u201381.","journal-title":"Curr Opin Rheumatol"},{"issue":"6375","key":"456_CR104","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.286.6375.1442-a","volume":"286","author":"MI Garlepp","year":"1983","unstructured":"Garlepp MI, Dawkins RL, Christiansen FT. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed). 1983;286(6375):1442.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"9","key":"456_CR105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","volume":"122","author":"PH Plotz","year":"1995","unstructured":"Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med. 1995;122(9):715\u201324.","journal-title":"Ann Intern Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-014-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-014-0456-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-014-0456-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-014-0456-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:19:19Z","timestamp":1659089959000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-014-0456-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":105,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["456"],"URL":"https:\/\/doi.org\/10.1007\/s11910-014-0456-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]},"assertion":[{"value":"29 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"456"}}